Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Resilience in the Fight Against ALS cover art

Resilience in the Fight Against ALS

One Company's Journey of Courage, Commitment, and Ingenuity

Preview
Get this deal Free with 30-day trial
Offer ends on 28 December, 2026.
Prime logo
Only ₹5/month for first 3 months.
Get 1 credit per month to use on any title of your choice.
Listen to anything from the Plus Catalogue—thousands of audiobooks, podcasts, and Audible Originals.
₹199/month after first 3 months. Cancel anytime. Renews automatically. Offer ends 28 December, 2026.
1 credit a month to use on any title to download and keep
Listen to anything from the Plus Catalogue—thousands of Audible Originals, podcasts and audiobooks
Download titles to your library and listen offline
₹199.00 per month after 30-day trial. Cancel anytime.

Resilience in the Fight Against ALS

Written by: Cytokinetics
Narrated by: Kyla Garcia
Free with 30-day trial Free with 30-day trial

₹199.00 per month after 30-day trial. Cancel anytime.

₹199.00 per month after 30-day trial. Cancel anytime.

Buy Now for ₹378.16

Buy Now for ₹378.16

About this listen

For over a decade, Cytokinetics, a biopharmaceutical company, has been at the forefront of the fight to discover new potential therapies for people living with ALS. Ultimately, the company was unsuccessful in bringing forward a new medicine for people with ALS, and while some might see this as a story ending in failure, it is anything but. This book shares the company’s journey—inspired and guided by the extraordinary members of the greater ALS community.

That journey began with an innovative idea: What if a therapy could focus on muscle function, not just on neurons? The company used their expertise in the mechanics of muscle to investigate this novel approach, giving rise to the discovery and development of two investigational medicines. Many people with ALS—in a heroic show of grace, strength, and bravery—lent their advice and volunteered to participate in clinical trials. While a cure for ALS and other neuromuscular diseases still remains, sadly, out of reach, the connection between company and community endures.

This book shares the experience and learnings that Cytokinetics gained, and serves as a way to pass the baton to other members of the industry and the scientific community who are dedicated to bringing forward new therapies in the hopes that it will honor all those who participated and shine a light on the path forward.

©2024 Cytokinetics Cytokinetics (P)2024 Melcher Media Inc
Medicine & Health Care Industry Physical Illness & Disease
adbl_web_anon_alc_button_suppression_t1
No reviews yet